Ao San Camillo Forlanini

Roma 00152

1 studies enrolling now · 8 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Atrial Fibrillation, Cardiovascular Diseases, Crohn's Disease, Diabetes Mellitus, Type 2, Hypertension, Ischemic Stroke, Primary Mediastinal B-cell Lymphoma, Secondary Prevention, Stroke, Ulcerative Colitis and Crohn's Disease

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma — Running, not enrolling
• ASSIST Registry Studying Various Operator Techniques — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed